Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$280M |
| 3 |
Morgan Stanley
MS
|
+$265M |
| 4 |
American Tower
AMT
|
+$262M |
| 5 |
Charles Schwab
SCHW
|
+$261M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$132M |
Sector Composition
| 1 | Technology | 24.26% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Castle Biosciences
CSTL
$627M
| $15.6M | ﹤0.01% |
233,037
+26,280
| +13% | +$1.76M |
|
|
VIVO
1877
DELISTED
Meridian Bioscience Inc
VIVO
| $15.6M | ﹤0.01% |
837,224
+59,201
| +8% | +$1.11M |
|
1878
Oxford Industries
OXM
$695M
| $15.6M | ﹤0.01% |
238,848
+3,257
| +1% | +$213K |
|
1879
Sonic Automotive
SAH
$2.69B
| $15.6M | ﹤0.01% |
405,172
-27,774
| -6% | -$1.07M |
|
|
EPZM
1880
DELISTED
Epizyme, Inc
EPZM
| $15.6M | ﹤0.01% |
1,437,596
+81,617
| +6% | +$886K |
|
1881
ALX Oncology
ALXO
$56.2M
| $15.6M | ﹤0.01% |
180,868
+26,239
| +17% | +$2.26M |
|
1882
Pitney Bowes
PBI
$1.96B
| $15.5M | ﹤0.01% |
2,520,650
+70,864
| +3% | +$437K |
|
1883
TriCo Bancshares
TCBK
$1.47B
| $15.4M | ﹤0.01% |
437,907
+8,684
| +2% | +$306K |
|
|
VNE
1884
DELISTED
Veoneer, Inc.
VNE
| $15.4M | ﹤0.01% |
724,976
+27,347
| +4% | +$582K |
|
1885
Myers Industries
MYE
$598M
| $15.4M | ﹤0.01% |
741,981
-1,381
| -0.2% | -$28.7K |
|
|
EBIX
1886
DELISTED
Ebix Inc
EBIX
| $15.2M | ﹤0.01% |
401,171
+15,926
| +4% | +$605K |
|
1887
KE Holdings
BEKE
$23.2B
| $15.1M | ﹤0.01% |
248,461
+15,836
| +7% | +$965K |
|
1888
CEVA Inc
CEVA
$586M
| $15.1M | ﹤0.01% |
332,685
+15,312
| +5% | +$697K |
|
1889
Korro Bio
KRRO
$294M
| $15.1M | ﹤0.01% |
8,584
+231
| +3% | +$407K |
|
1890
PMV Pharmaceuticals
PMVP
$60.4M
| $15.1M | ﹤0.01% |
245,844
+212,844
| +645% | +$13.1M |
|
1891
e.l.f. Beauty
ELF
$8.19B
| $15.1M | ﹤0.01% |
597,550
+40,101
| +7% | +$1.01M |
|
|
INVX
1892
Innovex International, Inc.
INVX
$1.14B
| $15M | ﹤0.01% |
506,462
+10,481
| +2% | +$310K |
|
1893
Smith & Wesson
SWBI
$419M
| $15M | ﹤0.01% |
843,855
+28,356
| +3% | +$503K |
|
1894
National Bank Holdings
NBHC
$1.44B
| $14.9M | ﹤0.01% |
455,849
+9,149
| +2% | +$300K |
|
1895
Patterson-UTI
PTEN
$2.08B
| $14.9M | ﹤0.01% |
2,837,243
+4,863
| +0.2% | +$25.6K |
|
|
UHT
1896
Universal Health Realty Income Trust
UHT
$582M
| $14.9M | ﹤0.01% |
231,225
-11,288
| -5% | -$725K |
|
|
RTL
1897
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $14.8M | ﹤0.01% |
1,997,341
+315,250
| +19% | +$2.34M |
|
1898
S&T Bancorp
STBA
$1.48B
| $14.8M | ﹤0.01% |
596,152
-3,364
| -0.6% | -$83.6K |
|
|
RWT
1899
Redwood Trust
RWT
$793M
| $14.8M | ﹤0.01% |
1,686,528
+860
| +0.1% | +$7.55K |
|
1900
Adverum Biotechnologies
ADVM
$64.4M
| $14.8M | ﹤0.01% |
136,441
+6,747
| +5% | +$731K |
|